DELALUTIN |
010347 |
002 |
NDA |
HYDROXYPROGESTERONE CAPROATE |
SOLUTION;INTRAMUSCULAR |
250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
--
|
Approved Prior to Jan 1, 1982
|
BRISTOL MYERS SQUIBB |
Discontinued |
DELALUTIN |
010347 |
004 |
NDA |
HYDROXYPROGESTERONE CAPROATE |
SOLUTION;INTRAMUSCULAR |
125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
--
|
Approved Prior to Jan 1, 1982
|
BRISTOL MYERS SQUIBB |
Discontinued |
DELALUTIN |
016911 |
001 |
NDA |
HYDROXYPROGESTERONE CAPROATE |
SOLUTION;INTRAMUSCULAR |
125MG/ML (125MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
--
|
Approved Prior to Jan 1, 1982
|
BRISTOL MYERS SQUIBB |
Discontinued |
DELALUTIN |
016911 |
002 |
NDA |
HYDROXYPROGESTERONE CAPROATE |
SOLUTION;INTRAMUSCULAR |
250MG/ML (250MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
Yes
|
No
|
--
|
Approved Prior to Jan 1, 1982
|
BRISTOL MYERS SQUIBB |
Discontinued |